Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.1426
Schlusskurs vom Vortag:
$0.1426
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$7.90M
Einnahmen:
$3.10M
Nettoeinkommen (Verlust:
$-97.43M
KGV:
0.00
EPS:
-1.8
Netto-Cashflow:
$-94.38M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$2.625
Omega Therapeutics Inc Stock (OMGA) Company Profile
Firmenname
Omega Therapeutics Inc
Sektor
Branche
Telefon
(617) 949-4360
Adresse
140 FIRST STREET, SUITE 501, CAMBRIDGE
Vergleichen Sie OMGA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMGA
Omega Therapeutics Inc
|
0.00 | 7.90M | 3.10M | -97.43M | -94.38M | -1.80 |
|
ONC
Beigene Ltd Adr
|
236.86 | 24.29B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.18 | 110.94B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2996 | 45.05M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
614.79 | 61.99B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
74.73 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Omega Therapeutics Inc Stock (OMGA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-06-18 | Eingeleitet | Raymond James | Outperform |
| 2023-05-25 | Fortgesetzt | Jefferies | Buy |
| 2022-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-09-23 | Eingeleitet | Chardan Capital Markets | Buy |
Omega Therapeutics Inc Aktie (OMGA) Neueste Nachrichten
Layoff Tracker: Allogene Cuts 28% of Staff to Extend Runway, Focus on Clinical Programs - BioSpace
Omega Therapeutics (NASDAQ:OMGA) Trading Down 21.8% – Time to Sell? - Defense World
Biotech Firm Omega Therapeutics OK'd For $14M Ch. 11 Sale - Law360
Q1 Biopharma Layoffs Hit California, Massachusetts Hard - BioSpace
Recursion Pharmaceuticals (NASDAQ:RXRX) & Omega Therapeutics (NASDAQ:OMGA) Critical Analysis - Defense World
OMEGA THERAPEUTICS INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus
Omega Therapeutics (OMGA) Projected to Post Earnings on Thursday - The AM Reporter
Omega Therapeutics (OMGA) to Release Quarterly Earnings on Thursday - Defense World
Flagship's Empress lays off 53% of staffers in push to get science to clinic - Fierce Biotech
Omega Therapeutics secures $9.8M in DIP financing - MSN
Programmable mRNA therapeutics for controlled epigenomic modulation of single and multiplexed gene expression in diverse diseases - Nature
Lila Sciences raises $200M to accelerate autonomous scientific research - SiliconANGLE
HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World
Struggling healthcare firm files for Chapter 11 bankruptcy - TheStreet
Petri Dish: Bankrupt Flagship firm sells assets; Nimbus hits milestone - The Business Journals
OMEGA THERAPEUTICS INC Revenue Breakdown – OTC:OMGAQ - TradingView
Two new option listings and eighteen option delistings on February 25th - TipRanks
Omega Therapeutics to sell assets amid Nasdaq delisting By Investing.com - Investing.com India
Omega Therapeutics to sell assets amid Nasdaq delisting - Investing.com
Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & Immunology - GlobeNewswire
Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle - HPBL
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Finanzdaten der Omega Therapeutics Inc-Aktie (OMGA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.33%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):